BEIJING HOLLEY-COTEC PHARMACEUTICALS CO. LTD.   Report issue

For profit Phase 3 Phase 4
Founded: Beijing China (1993)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2007
NCT00845533
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Holley-Cotec Pharmaceuticals Co., LTD.

Active Ingredients

Drugs in Phase 4 Trials (2)

dihydroartemisinin (1 trial)

piperaquine (2 trials)

Drugs in Phase 3 Trials (4)

amodiaquine (camoquin) (1 trial)

artemisinin (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 6